Uveitogenicity is associated with a Th1-like lymphokine profile: Cytokine-dependent modulation of early and committed effector T cells in experimental autoimmune uveitis

Cellular Immunology

Volumn 178, Issue 1, 1997, Pages 69-78

  Xu, Hui ^a   Rizzo, Luiz V ^a   Silver, Phyllis B ^a   Caspi, Rachel R ^a  

^a NATIONAL EYE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; RETINOID BINDING PROTEIN; SYNTHETIC PEPTIDE; TRANSFORMING GROWTH FACTOR BETA;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; CELL LINE; CONTROLLED STUDY; ETIOLOGY; FEMALE; IMMUNIZATION; LYMPH NODE CELL; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE; UVEORETINITIS;

ANIMALIA;

EID: 0031586024     PISSN: 00088749     EISSN: None     Source Type: Journal    
DOI: 10.1006/cimm.1997.1121     Document Type: Article

References (42)

1. Nussenblatt R. B., Kuwabara T., de Monasterio F. M., Wacker W. B. S-antigen uveitis in primates. A new model for human disease. Arch. Ophthalmol. 99:1981;1090.
2. Fox G. M., Kuwabara T., Wiggert B., Redmond T. M., Hess H. H., Chader G. J., Gery I. Experimental autoimmune uveoretinitis (EAU) induced by retinal interphotoreceptor retinoid-binding protein (IRBP): Differences between EAU induced by IRBP and by S-antigen. Clin. Immunol. Immunopathol. 43:1987;256.
3. Caspi R. R., Roberge F. G., Chan C. C., Wiggert B., Chader G. J., Rozenszajn L. A., Lando Z., Nussenblatt R. B. A new model of autoimmune disease. Experimental autoimmune uveoretinitis induced in mice with two different retinal antigens. J. Immunol. 140:1988;1490.
4. Nussenblatt R. B., Whitcup S. M., Palestine A. G. Uveitis: Fundamentals and Clinical Practice. 1996;Mosby-Year Book, St. Louis. p. 22-26.
5. Caspi R. R., Roberge F. G., McAllister C. G., el-Saied M., Kuwabara T., Gery I., Hanna E., Nussenblatt R. B. T cell lines mediating experimental autoimmune uveoretinitis (EAU) in the rat. J. Immunol. 136:1986;928.
6. Rizzo L. V., Silver P., Wiggert B., Hakim F., Gazzinelli R. T., Chan C. C., Caspi R. R. Establishment and characterization of a murine CD4+ T cell line and clone that induce experimental autoimmune uveoretinitis in B10.A mice. J. Immunol. 156:1996;1654.
7. Mosmann T. R., Coffman R. L. TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:1989;145.
8. Romagnani S. Type 1 T helper and type 2 T helper cells: Functions, regulation and role in protection and disease. Int. J. Clin. Lab. Res. 21:1991;152.
9. Trinchieri G. Interleukin-12 and its role in the generation of TH1 cells. Immunol. Today. 14:1993;335.
10. Evavold B. D., Sloan-Lancaster J., Allen P. M. Tickling the TCR: Selective T-cell functions stimulated by altered peptide ligands. Immunol. Today. 1:1993;602.
11. Pfeiffer C., Stein J., Southwood S., Ketelaar H., Sette A., Bottomly K. Altered peptide ligands can control CD4 T lymphocyte differentiationin vivo. J. Exp. Med. 181:1995;1569.
12. Caspi R. R., Silver P. B., Chan C. C., Sun B., Agarwal R. K., Wells J., Oddo S., Fujino Y., Najafian F., Wilder R. L. Genetic susceptibility to experimental autoimmune uveoretinitis (EAU) in the rat is associated with an elevated Th1 response. J. Immunol. 157:1996;2668.
13. Silver P. B., Rizzo L. V., Chan C. C., Donoso L. A., Wiggert B., Caspi R. R. Identification of a major pathogenic epitope in the human IRBP molecule recognized by mice of the H-2r haplotype. Invest. Ophthalmol. Vis. Sci. 36:1995;946.
14. Savion S., Oddo S., Grover S., Caspi R. R. Uveitogenic T lymphocytes in the rat: Pathogenicity vs. lymphokine production, adhesion molecules and surface antigen expression. J. Neuroimmunol. 55:1994;35.
15. Caspi R. R. Experimental autoimmune uveoretinitis - Rat and mouse. Animal Models for Autoimmune Diseases: A Guidebook. 1994;Academic Press, San Diego. p. 57-.
16. Saoudi A., Kuhn J., Huygen K., de Kozak Y., Velu T., Goldman M., Druet P., Bellon B. TH2 activated cells prevent experimental autoimmune uveoretinitis, a TH1-dependent autoimmune disease. Eur. J. Immunol. 23:1993;3096.
17. Caspi R. R. Th1 and Th2 lymphocytes in experimental autoimmune uveoretinitis. International Congress Series. 1994;55.
18. Mochizuki M., Kuwabara T., McAllister C., Nussenblatt R. B., Gery I. Adoptive transfer of experimental autoimmune uveoretinitis in rats. Immunopathogenic mechanisms and histologic features. Invest. Ophthalmol. Vis. Sci. 26:1985;1.
19. Driscoll B., Kies M., Alvord E. Transfer of experimental allergic encephalomyelitis (EAE) with guinea pig peritoneal exudate cells. Science. 203:1979;547.
20. Richert J., Driscoll B., Kies M., Alvord E. Adoptive transfer of experimental allergic encephalomyelitis. Incubation of rat spleen cells with specific antigen. J. Immunol. 122:1979;494.
21. Schmitt E., Hoehn P., Germann T., Rude E. Differential effects of interleukin-12 on the development of naive mouse CD4+ T cells. Eur. J. Immunol. 24:1994;343.
22. Sun B., Sun S. H., Caspi R. R. Genetic susceptibility to EAU involves more than a predisposition to generate a Th1 or a Th2-type response. Invest. Ophthalmol. Vis. Sci. 37:1996;S538.
23. von Freeden-Jeffry U., Vieira P., Lucian L. A., McNeil T., Burdach S. E., Murray R. Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. J. Exp. Med. 181:1995;1519.
24. Racke M. K., Dhib-Jalbut S., Cannella B., Albert P. S., Raine C. S., McFarlin D. E. Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-beta 1. J. Immunol. 146:1991;3012.
25. Johns L. D., Flanders K. C., Ranges G. E., Sriram S. Successful treatment of experimental allergic encephalomyelitis with transforming growth factor-beta 1. J. Immunol. 147:1991;1792.
26. Santambrogio L., Hochwald G. M., Saxena B., Leu C. H., Martz J. E., Carlino J. A., Ruddle N. H., Palladino M. A., Gold L. I., Thorbecke G. J. Studies on the mechanisms by which transforming growth factor-beta (TGF-beta) protects against allergic encephalomyelitis. Antagonism between TGF-beta and tumor necrosis factor. J. Immunol. 151:1993;1116.
27. Christ M., McCartney-Francis N. L., Kulkarni A. B., Ward J. M., Mizel D. E., Mackall C. L., Gress R. E., Hines K. L., Tian H., Karlsson S. Immune dysregulation in TGF-beta 1-deficient mice. J. Immunol. 153:1994;1936.
28. Yaswen L., Kulkarni A. B., Fredrickson T., Mittleman B., Schiffman R., Payne S., Longenecker G., Mozes E., Karlsson S. Autoimmune manifestations in the transforming growth factor-beta 1 knockout mouse. Blood. 87:1996;1439.
29. Powrie F., Carlino J., Leach M. W., Mauze S., Coffman R. L. A critical role for transforming growth factor-beta but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB(low) CD4+ T cells. J. Exp. Med. 183:1996;2669.
30. Holter W., Kalthoff F. S., Pickl W. F., Ebner C., Majdic O., Kraft D., Knapp W. Transforming growth factor-beta inhibits IL-4 and IFN-gamma production by stimulated human T cells. Int. Immunol. 6:1994;469.
31. Cerwenka A., Bevec D., Majdic O., Knapp W., Holter W. TGF-beta 1 is a potent inducer of human effector T cells. J. Immunol. 153:1994;4367.
32. Karpus W. J., Swanborg R. H. CD4+ suppressor cells inhibit the function of effector cells of experimental autoimmune encephalomyelitis through a mechanism involving transforming growth factor-beta. J. Immunol. 146:1991;1163.
33. Weinberg A. D., Whitham R., Swain S. L., Morrison W. J., Wyrick G., Hoy C., Vandenbark A. A., Offner H. Transforming growth factor-beta enhances thein vivo. J. Immunol. 148:1992;2109.
34. Schluesener H. J., Lider O. Transforming growth factors beta 1 and beta 2: Cytokines with identical immunosuppressive effects and a potential role in the regulation of autoimmune T cell function. J. Neuroimmunol. 24:1989;249.
35. Cousins S. W., McCabe M. M., Danielpour D., Streilein J. W. Identification of transforming growth factor-beta as an immunosuppressive factor in aqueous humor. Invest. Ophthalmol. Vis. Sci. 32:1991;2201.
36. Anderson D. H., Guerin C. J., Hageman G. S., Pfeffer B. A., Flanders K. C. Distribution of transforming growth factor-beta isoforms in the mammalian retina. J. Neurosci. Res. 42:1995;63.
37. Zheng L., Fisher G., Miller R. E., Peschon J., Lynch D. H., Lenardo M. J. Induction of apoptosis in mature T cells by tumour necrosis factor. Nature. 377:1995;348.
38. de Kozak Y., Naud M. C., Bellot J., Faure J. P., Hicks D. Differential tumor necrosis factor expression by resident retinal cells from experimental uveitis-susceptible and -resistant rat strains. J. Neuroimmunol. 55:1994;1.
39. Tanihara H., Yoshida M., Yoshimura N. Tumor necrosis factor-alpha gene is expressed in stimulated retinal pigment epithelial cells in culture. Biochem. Biophys. Res. Commun. 187:1992;1029.
40. Rabinovitch A., Suarez-Pinzon W. L., Sorensen O., Bleackley R. C., Power R. F., Rajotte R. V. Combined therapy with interleukin-4 and interleukin-10 inhibits autoimmune diabetes recurrence in syngeneic islet-transplanted nonobese diabetic mice. Analysis of cytokine mRNA expression in the graft. Transplantation. 60:1995;368.
41. Sartani G., Silver P. B., Rizzo L. V., Chan C.-C., Wiggert B., Mastorakos G., Caspi R. R. Anti-TNF therapy suppresses induction of experimental autoimmune uveoretinitis in mice by inhibiting antigen priming. Invest. Ophthalmol. Vis. Sci. 37:1996;2211.
42. Caspi R. R., Chan C. C., Grubbs B. G., Silver P. B., Wiggert B., Parsa C. F., Bahmanyar S., Billiau A., Heremans H. Endogenous systemic IFN-gamma has a protective role against ocular autoimmunity in mice. J. Immunol. 152:1994;890.